About Shaun Hawkins
Shaun Hawkins is a director of ZeroCarb and GeniPhys. He is also a managing partner at Pier 70 Ventures and ProSyte Companies, which he founded in 2015. He serves on Invesque's board.
At Eli Lilly, Hawkins held licensing and business-development roles from 2001 to 2009. He was chief diversity officer through 2012 and led new ventures and private equity through 2015. He advised Epidarex Capital, TVM Life Sciences and Carrick Therapeutics. He chaired Audion and Muroplex and served on the Accelerator, ImmuneWorks and Zymeworks boards. He also sat on advisory committees for BioCrossroads' Indiana Enterprise Fund, Epidarex Capital, Indiana Future Fund/INext Fund and TVM Capital.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Shaun Hawkins in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Shaun Hawkins works with at each company, as listed on that company's latest Form D.